Increased blood and/or CSF NfL levels have been reported in ALS patients (Xu et al., 2016; Verde et al., 2019), reflecting axonal damage of motor neurons during disease progression. The gene discussed is NEFL; the disease is amyotrophic lateral sclerosis.